Once you start taking Mavakatai, can you stop taking it midway and what are the risks?

Mavacamten is a selective cardiac myosin inhibitor mainly used to treat hypertrophic cardiomyopathy (HCM). Since its mechanism of action directly affects myocardial contractile function, once you start taking it, stopping it at will may bring certain risks, so you need to strictly follow the doctor's instructions.

Mavakate can inhibit cardiac myosinATP enzyme activity, reduce excessive myocardial contraction and reduce left ventricular outflow tract pressure, thereby improving cardiac function and symptoms. If the drug is suddenly stopped midway, the inhibitory effect of the drug disappears, and myocardial hypercontraction may quickly resume, resulting in an increase in left ventricular outflow tract pressure and an increased risk of heart failure, arrhythmia, or symptom exacerbation.

Clinical studies have shown that long-term regular use of Mavaceta can stabilize heart function and improve exercise tolerance. Unauthorized withdrawal of medication may cause the originally controlled cardiac load to increase again, and symptoms may rebound significantly, such as chest tightness, dyspnea, and decreased exercise tolerance. This is particularly dangerous for patients with hypertrophic cardiomyopathy, which may induce acute heart failure or abnormal heart rhythms.

Therefore, patients should take medication regularly in accordance with the dosage and course of treatment prescribed by their doctor while taking Mavakatai. If it is necessary to discontinue the drug or adjust the dose, it should be gradually adjusted under the supervision of a doctor and cardiac function assessment should be performed. Doctors usually combine echocardiography, electrocardiography and symptom changes to determine the feasibility of stopping or reducing medication to ensure medication safety and avoid the risk of cardiac events.

In summary, once you start taking Mavaceta, it is not recommended to stop taking it at will. Unauthorized discontinuation of medication may result in recovery of myocardial hypercontraction, rebound of symptoms, and increased risk of serious cardiac events. All dosage adjustments or drug withdrawal operations must be performed under the guidance of a professional doctor and combined with cardiac function monitoring to ensure patient safety and stable efficacy.

Reference materials:https://www.drugs.com/